KA: Kineta Inc Stock Price Quote - NASDAQ CM - Bloomberg
Search
    Search

      Kineta Inc
      KA:US

      Nasdaq CM (USD)· Market closed
      Arrow Down
      –0.03–4.66%
      As of.

      Overview

      Key Statistics

      Related News

      Kineta, Inc. is a clinical-stage bio-pharmaceutical company. The Company focuses on the discovery and development of adaptive immunity and T cell therapies for the treatments for neuro-degenerative diseases. Kineta operates in the United States.

      219 Terry Ave North Suite 300 Seattle, WA 98109 United States

      Income Statement

      Annual

      Balance Sheet

      Overview

      Key Statistics